Clinical biology of the pituitary adenoma
S Melmed, UB Kaiser, MB Lopes, J Bertherat… - Endocrine …, 2022 - academic.oup.com
All endocrine glands are susceptible to neoplastic growth, yet the health consequences of
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …
Endocrine disrupting chemicals: effects on endocrine glands
In recent years, endocrine disrupting chemicals have gained interest in human
physiopathology and more and more studies aimed to explain how these chemicals …
physiopathology and more and more studies aimed to explain how these chemicals …
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)
RV Thakker, PJ Newey, GV Walls… - The Journal of …, 2012 - academic.oup.com
Objective: The aim was to provide guidelines for evaluation, treatment, and genetic testing
for multiple endocrine neoplasia type 1 (MEN1). Participants: The group, which comprised …
for multiple endocrine neoplasia type 1 (MEN1). Participants: The group, which comprised …
Clinical and molecular genetics of the phosphodiesterases (PDEs)
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that have the unique function of
terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They …
terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They …
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) …
Pituitary adenomas are one of the most frequent intracranial tumors and occur with a
prevalence of approximately 1: 1000 in the developed world. Pituitary adenomas have a …
prevalence of approximately 1: 1000 in the developed world. Pituitary adenomas have a …
Pathogenesis of pituitary tumors
S Melmed - Nature Reviews Endocrinology, 2011 - nature.com
Pituitary adenomas may hypersecrete hormones (including prolactin, growth hormone and
adrenocorticotropic hormone, and rarely follicle-stimulating hormone, luteinizing hormone or …
adrenocorticotropic hormone, and rarely follicle-stimulating hormone, luteinizing hormone or …
Acromegaly
P Chanson, S Salenave - Orphanet journal of rare diseases, 2008 - Springer
Acromegaly is an acquired disorder related to excessive production of growth hormone (GH)
and characterized by progressive somatic disfigurement (mainly involving the face and …
and characterized by progressive somatic disfigurement (mainly involving the face and …
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study
AF Daly, MA Tichomirowa, P Petrossians… - The Journal of …, 2010 - academic.oup.com
Context: AIP mutations (AIPmut) give rise to a pituitary adenoma predisposition that occurs
in familial isolated pituitary adenomas and less often in sporadic cases. The clinical and …
in familial isolated pituitary adenomas and less often in sporadic cases. The clinical and …
Management of hormone-secreting pituitary adenomas
Pituitary adenomas are one of the most common primary central nervous system tumors and
have an estimated prevalence of 17%. Approximately half of pituitary adenomas secrete …
have an estimated prevalence of 17%. Approximately half of pituitary adenomas secrete …
Novel insights into pituitary tumorigenesis: genetic and epigenetic mechanisms
V Srirangam Nadhamuni, M Korbonits - Endocrine reviews, 2020 - academic.oup.com
Substantial advances have been made recently in the pathobiology of pituitary tumors.
Similar to many other endocrine tumors, over the last few years we have recognized the role …
Similar to many other endocrine tumors, over the last few years we have recognized the role …